Gender Specific Responses of Overweight and Obese Adults to Sprint Interval Training
1 other identifier
interventional
35
1 country
1
Brief Summary
Overweight and Obesity is a growing health problem worldwide. Lifestyle changes such as decreased physical activity, increased sedentary behaviour and unhealthy eating habits has contribute to this problem. According to World Health Organization (2016), more than 1.9 billion adults aged 18 years and older were overweight (39% of men and 40% of women).Regular exercise is the key contributor to energy expenditure and is essential for energy balance and weight control. Interval training (IT) has been commonly used for decades with purpose to improve body health and reduce weight loss and this exercise differs from the conventional aerobic exercise and endurance exercise as IT typically involves repeated bouts of relatively intense exercise interspersed by periods of lower- intensity effort or complete rest for recovery. One of the most common type of IT is sprint interval training (SIT). SIT involves 'supramaximal' effort (\>100% VO2max) work bouts, traditionally structured as four to six 30s all-out effort and each round separated by 4 minutes of recovery period of a low intensity exercise. Potential physiological adaptation of SIT are highlighted by various studies reporting cardiovascular, skeletal muscle adaptations, increase fat oxidation that facilitate increases in both aerobic and anaerobic performance. In addition, SIT is able to improve maximal rate of oxygen consumption (VO2max), at the same time improving the peripheral vascular structure and function, enzymes of fat metabolism and increases insulin sensitivity. Previous SIT studies have included young healthy men and women, healthy obese young women, all of which have shown that SIT is effective for fat loss and improvement of some health parameters. However, whether SIT protocol is equally effective in improving the anthropometric measures in men and women remain unknown.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Feb 2020
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 4, 2019
CompletedFirst Posted
Study publicly available on registry
November 7, 2019
CompletedStudy Start
First participant enrolled
February 4, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 16, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
November 23, 2020
CompletedNovember 24, 2020
November 1, 2020
10 months
November 4, 2019
November 22, 2020
Conditions
Outcome Measures
Primary Outcomes (5)
BMI for change
At baseline (before intervention begin) and post training (end of 6 weeks).
Waist Circumference for change
At baseline (before intervention begin) and post training (end of 6 weeks).
Total Fat % for change
At baseline (before intervention begin) and post training (end of 6 weeks).
Lean Muscle Mass for change
At baseline (before intervention begin) and post training (end of 6 weeks).
skin Fold Measurement for change
At baseline (before intervention begin) and post training (end of 6 weeks).
Study Arms (2)
SIT for males
EXPERIMENTALSIT for females
EXPERIMENTALInterventions
Sprint interval training of 4\*4, with 30 seconds of all out workout followed by 4 minutes of active recovery for 4 cycles.
Eligibility Criteria
You may qualify if:
- BMI≧23kg/m2(WHO for Asia-Pacific region)
- No history of metabolic, hormonal, orthopedic, or cardiovascular diseases
- No current use of prescribed medication including oral contraception
You may not qualify if:
- Contraindications to physical activity assessed by Physical Activity Readiness Questionnaire-PAR-Q
- Undergoes any surgical or hormone treatment
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Universiti Tunku Abdul Rahman
Kajang, Selangor, 43000, Malaysia
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Imtiyaz Ali Mir
Universiti Tunku Abdul Rahman
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
November 4, 2019
First Posted
November 7, 2019
Study Start
February 4, 2020
Primary Completion
November 16, 2020
Study Completion
November 23, 2020
Last Updated
November 24, 2020
Record last verified: 2020-11
Data Sharing
- IPD Sharing
- Will not share